What is X2 Biosystems?
X2 Biosystems operates at the intersection of mobile technology and clinical neurology, specifically addressing the critical need for standardized concussion management. The company is best known for its Integrated Concussion Evaluation (ICE) Application, a platform that streamlines the administration of the Sports Concussion Assessment Tool (SCAT). By providing a HIPAA-compliant framework for real-time data exchange between athletic trainers, team physicians, and medical specialists, X2 Biosystems enables rapid, evidence-based decision-making. The platform supports comprehensive neurocognitive baseline testing and post-impact monitoring, effectively digitizing the diagnostic workflow for high-performance athletic organizations and healthcare providers globally.
How much funding has X2 Biosystems raised?
X2 Biosystems has raised a total of $10.2M across 4 funding rounds:
Debt
$2M
Unspecified
$3.3M
Debt
$720K
Debt
$4.2M
Debt (2010): $2M, investors not publicly disclosed
Unspecified (2012): $3.3M, investors not publicly disclosed
Debt (2013): $720K, investors not publicly disclosed
Debt (2014): $4.2M, investors not publicly disclosed
Key Investors in X2 Biosystems
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for X2 Biosystems?
With the successful completion of its recent financing round, X2 Biosystems is well-positioned to expand its enterprise-level footprint. The company is expected to focus on enhancing its software interoperability and deepening its integration with existing electronic health record systems. As the regulatory environment for athlete safety continues to evolve, the firm's ability to provide secure, scalable, and customizable diagnostic templates will be a primary driver of its long-term growth. Future strategic initiatives will likely prioritize the adoption of its mobile diagnostic suite across professional leagues and collegiate athletic departments, further cementing its role as a standard-bearer in concussion assessment technology.
See full X2 Biosystems company page
